I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 26 studies | 33% ± 10% | |
| CD16-positive, CD56-dim natural killer cell, human | 14 studies | 46% ± 15% | |
| mature NK T cell | 11 studies | 26% ± 11% | |
| CD16-negative, CD56-bright natural killer cell, human | 9 studies | 27% ± 9% | |
| adipocyte | 6 studies | 21% ± 6% | |
| epithelial cell of proximal tubule | 5 studies | 18% ± 1% | |
| epithelial cell | 5 studies | 25% ± 10% | |
| hepatocyte | 5 studies | 48% ± 18% | |
| CD8-positive, alpha-beta T cell | 4 studies | 21% ± 3% | |
| gamma-delta T cell | 4 studies | 25% ± 4% | |
| astrocyte | 3 studies | 20% ± 4% | |
| endothelial cell | 3 studies | 19% ± 3% |
